Biogen (BIIB) call put ratio 2.1 calls to 1 put as shares rally 9.5%

Go back to Biogen (BIIB) call put ratio 2.1 calls to 1 put as shares rally 9.5%

Samsung BioLogics Said Biogen (BIIB) Buyout Rumor 'Untrue'

December 29, 2021 11:59 PM EST

Samsung BioLogics said a report that Samsung Group was in talks to acquire Biogen Inc. (NASDAQ: BIIB) is not true.

... More

Biogen (BIIB) Could be Valued at $42B Cash in Samsung Deal, Here Are Key Questions According to Truist Securities

December 29, 2021 5:01 PM EST

Truist analyst Robyn Karnauskas reiterates a "Buy" rating and $502 price target on shares of Biogen (NASDAQ: BIIB), following rumors of potential takeover of the company by Samsung Group.

The analyst quotes:

"While there is no price set yet, Biogen approached Samsung to... More